Literature DB >> 28101614

[Dermatological topical and systemic therapy during pregnancy].

S Grunewald1, P Staubach2.   

Abstract

During pregnancy, a successful and safe therapeutic management of patients is possible to lower the burden of disease. Often topical therapy in combination with intensive basic skin care is sufficient. Drug therapies may also be used, most often for systemic diseases such as autoimmune diseases or psoriasis. An early change in therapy is also key during planned pregnancies so that treatments can be switched, adjusted, reduced or closely monitored. Another point to consider is to keep drug dosing as low as possible (without occlusion in local therapy) or short termed (with the exception of autoimmune or malignant diseases). An interdisciplinary collaboration between obstetrics and gynecology/rheumatology/internal medicine/dermatology as well as pharmacologists is of utmost importance.

Entities:  

Keywords:  Antibiotics; Antiinflammatory drugs; Biologics; Medication safety; Oncologic therapy

Mesh:

Substances:

Year:  2017        PMID: 28101614     DOI: 10.1007/s00105-016-3921-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG.

Authors:  Regina Treudler; Friederike Kauer; Jan Christoph Simon
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

Review 2.  Physiological and biological skin changes in pregnancy.

Authors:  Maya M Muallem; Nelly G Rubeiz
Journal:  Clin Dermatol       Date:  2006 Mar-Apr       Impact factor: 3.541

3.  Treatment of metastatic malignant melanoma with vemurafenib during pregnancy.

Authors:  Aglaia Maleka; Gunilla Enblad; Gunnar Sjörs; Anna Lindqvist; Gustav J Ullenhag
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

4.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

5.  Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.

Authors:  Kuldeep Cheent; Jonathan Nolan; Sohail Shariq; Liina Kiho; Arabinda Pal; Jayantha Arnold
Journal:  J Crohns Colitis       Date:  2010-06-09       Impact factor: 9.071

Review 6.  Drugs for preventing malaria in pregnant women.

Authors:  P Garner; A M Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Cyclophosphamide for lupus during pregnancy.

Authors:  M E B Clowse; L Magder; M Petri
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 8.  Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis.

Authors:  Jie Li; Yang Chen; Chengjun Liu; Yanling Hu; Liuming Li
Journal:  Am J Reprod Immunol       Date:  2013-12       Impact factor: 3.886

9.  In utero exposure to mycophenolate mofetil: a characteristic phenotype?

Authors:  Antonio Perez-Aytes; Ana Ledo; Virginia Boso; Pilar Sáenz; Eva Roma; José Luis Poveda; Maximo Vento
Journal:  Am J Med Genet A       Date:  2008-01-01       Impact factor: 2.802

Review 10.  Antifungal drugs during pregnancy: an updated review.

Authors:  Benoît Pilmis; Vincent Jullien; Jack Sobel; Marc Lecuit; Olivier Lortholary; Caroline Charlier
Journal:  J Antimicrob Chemother       Date:  2014-09-08       Impact factor: 5.790

View more
  1 in total

1.  [Tretinoin : One retinoid, many dosage forms].

Authors:  A Melhorn
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.